Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy and Safety of PQ Grass in Subjects With Seasonal Allergic Rhinitis and/or Rhinoconjunctivitis Induced by Grass Pollen Exposure

NCT05540717 is registered in ClinicalTrials.gov with Allergy Therapeutics as lead sponsor.

NCT NCT05540717
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05540717 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy and Safety of PQ Grass in Subjects With Seasonal Allergic Rhinitis and/or Rhinoconjunctivitis Induced by Grass Pollen Exposure
Lead sponsor
Allergy Therapeutics
Phase
Phase 3
Overall status
Completed
Start date
October 11, 2022
Completion date
November 1, 2023
Enrollment
555 (actual)
Sites
102

Conditions

As the registry lists them; a condition with its own page is linked.

rhinoconjunctivitis, seasonal allergic rhinitis